Montreal, Canada, is making significant strides in the life sciences sector. It’s home to a growing number of standout biotech firms specializing in areas like artificial intelligence, protein therapeutics, immunotherapies, and more. Nine of these companies, including Ability Biotherapeutics, Congruence Therapeutics, and Cura Therapeutics, have recently made notable advancements in their research, securing substantial seed funding and making progress on developing treatments for various illnesses, ranging from cancer and autoimmune diseases to rare genetic disorders and COVID-19.
Future of Healthcare Cybersecurity Market Trends & Innovations
The healthcare cybersecurity market is projected to grow from $20.2 billion in 2023 to $61.63 billion by 2031, a CAGR of 15.5%, according to a
